1. Top % Gainers: $BLPH 61%, $ENTA 21%, $BDC 18%, $ETE 18%, $CBM 18%, $MXL 15%, $SGI 15%, $CCXI 14%, $WTW 13%, $MYM 13%, $NYMX 12%, $TEN $CBRX

  2. $ENTA Jumping in here.

  3. $ENTA Squeeeeeze!!!

  4. here you go $ENTA

  5. $ENTA

  6. $ENTA watching for short HOD

  7. $ENTA nice

  8. $ENTA ,,Enanta Pharma Reports Q1 EPS $1.36 vs. Est. $1.13, Rev. $48.445M vs. Est. $47.05M

  9. $ENTA just posted a new conference call. Listen now: http://www.earningscalls.co/stocks/enta

  10. $ENTA Net income for $ENTA Dec Qtr was $26.2 million, $1.36 per share, compared vs $42.0 million or $2.18 same period 2014. No position.

  11. $ENTA: New SEC Filing for ENTA: Form 8-K, No. 0001193125-16-453842 http://stocknewsflow.com/1177648_000119312516453842_0001193125-16-453842

  12. $ENTA Enanta Pharma beats by $0.23, beats on revenue

  13. Enanta Pharmaceuticals Reports Financial Results For Its http://www.conferencecalltranscripts.org/8/summary/?id=2403912 $ENTA

  14. $ENTA Enanta Pharma Reports Q1 EPS $1.36 vs. Est. $1.13, Rev. $48.445M vs. Est. $47.05M

  15. Enanta Pharma Reports Q1 EPS $1.36 vs. Est. $1.13, Rev. $48.445M vs. Est. $47.05M $ENTA

  16. $ENTA is reporting today AMC, and is a potential signal for today EPS est $1.13 Rev est $47.05M @InvestieComp

  17. Earnings-Impact to Keep an Eye on Monday $PAGP, $YELP, $CSCD, $HAS, $BRS, $ENTA, $LII, $PINC, $OTTR, $FOX, $PSDV http://crweworld.com/article/markets/17531/notable-companies-earnings-reports-to-watch-for-monday-february-08-2016

  18. Most definite bounce candidates in biotech $SGEN $ENTA $DVAX $CMRX

  19. Tieton Capital Management, LLC appears to have added to its $ENTA position in the most recent quarter http://www.conferencecalltranscripts.org/summaryh/?id=2398877

  20. $ENTA ABBV up 5% and this continues to absolutly no love despite buying pressure. whatever

  21. $ENTA: New SEC Filing for ENTA: Form SC 13G/A, No. 0001144204-16-078709 http://stocknewsflow.com/1177648_000114420416078709_0001144204-16-078709

  22. Alan J. Dworsky just provided an update on share ownership of Enanta Pharmaceuticals Inc http://www.conferencecalltranscripts.org/13G/summary2/?id=2389887 $ENTA

  23. $ENTA Still approx. 1.5 mil untreated HVC patients in the US. Was 1.6 mil in 2015. HCV will remain a major market for a long time. $GILD

  24. $ENTA 4 millions shares short and counting.

  25. $ENTA All the weak hands should sell. Shorts should keep shorting. Future pipeline means nothing. Maybe this will have a P/E of 1 soon. IMO